Pacira BioSciences (PCRX) Interest Expenses (2010 - 2026)

Pacira BioSciences' Interest Expenses history runs 17 years deep, the most recent figure standing at $3.7 million for Q1 2026.

• In Q1 2026, Interest Expenses fell 19.24% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $16.6 million (down 7.11% YoY), while the FY2025 annual figure was $17.4 million, up 5.29% from the prior year.
• Interest Expenses was $3.7 million for Q1 2026 at Pacira BioSciences, down from $3.9 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $11.0 million in Q4 2022 to a low of $3.3 million in Q1 2024.
• Historically, Interest Expenses has averaged $5.8 million across 5 years, with a median of $4.6 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Interest Expenses jumped 46.98% in 2022, then sank 69.31% in 2023.
• A 5-year view of Interest Expenses shows it stood at $11.0 million in 2022, then slumped by 69.31% to $3.4 million in 2023, then soared by 38.13% to $4.7 million in 2024, then fell by 16.84% to $3.9 million in 2025, then decreased by 4.96% to $3.7 million in 2026.
• The last three Interest Expenses figures came in at $3.7 million (Q1 2026), $3.9 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.